Keywords: biogen, idec, 1st-qtr, profit, jumps, biotechnology, frm
Biogen Idec's 1st-qtr 2008 profit jumps 23%
Article | 05 May 2008
US biotechnology frm Biogen Idec's first-quarter 2008 profit rose 23% year-on-year, beating analyst expectations, thanks to strong sales of Avonex (interferon beta-1 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
